FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005524757> ?p ?o ?g. }

• W2005524757 endingPage "837" @default.
• W2005524757 startingPage "829" @default.
• W2005524757 abstract "Vitamin B12 (cyanocobalamin, Cbl) is accumulated by rapidly replicating prokaryotic and eukaryotic cells. We investigated the potential of a Tc-99m labelled Cbl derivative ([(99m)Tc]PAMA(4)-Cbl) for targeting infections caused by Escherichia coli and Staphylococcus aureus. In vitro binding assays were followed by biodistribution studies in a mouse model of foreign body infection.E. coli (ATCC 25922) and S. aureus (ATCC 43335) were used as test strains. [(57)Co]Cbl, [(67)Ga]citrate and [(99m)Tc]DTPA served as reference compounds. The in vitro competitive binding of [(57)Co]Cbl or [(99m)Tc]PAMA(4)-Cbl, and unlabeled Cbl, to viable or killed bacteria, was evaluated at 37 and 4 °C. A cage mouse model of infection was used for biodistribution of intravenous [(57)Co]Cbl and [(99m)Tc]PAMA(4)-Cbl in cage and dissected tissues of infected and non-infected mice.Maximum binding (mean ± SD) of [(57)Co]Cbl to viable E. coli was 81.7 ± 2.6 % and to S. aureus 34.0 ± 6.7 %, at 37 °C; no binding occurred to heat-killed bacteria. Binding to both test strains was displaced by 100- to 1000-fold excess of unlabeled Cbl. The in vitro binding of [(99m)Tc]PAMA(4)-Cbl was 100-fold and 3-fold lower than the one of [(57)Co]Cbl for E. coli and S. aureus, respectively. In vivo, [(99m)Tc]PAMA(4)-Cbl showed peak percentage of injected dose (% ID) values between 1.33 and 2.3, at 30 min post-injection (p.i.). Significantly higher retention occurred in cage fluids infected with S. aureus at 4 h and with E. coli at 8 h p.i. than in non-infected animals. Accumulation into infected cages was also higher than the one of [(99m)Tc]DTPA, which showed similar biodistribution in infected and sterile mice. [(57)Co]Cbl gradually accumulated in cages with peaks % ID between 3.58 and 4.83 % achieved from 24 to 48 h. Discrimination for infection occurred only in E. coli-infected mice, at 72 h p.i. [(67)Ga]citrate, which showed a gradual accumulation into cage fluids during 12 h, was discriminative for infection from 48 to 72 h p.i. (P < 0.05).Cbl displayed rapid and specific in vitro binding to test strains. [(99m)Tc]PAMA(4)-Cbl was rapidly cleared from most tissues and discriminated between sterile and infected cages, being a promising candidate for imaging infections in humans." @default.
• W2005524757 created "2016-06-24" @default.
• W2005524757 creator A5010369186 @default.
• W2005524757 creator A5027422217 @default.
• W2005524757 creator A5041743198 @default.
• W2005524757 creator A5062101314 @default.
• W2005524757 creator A5068817061 @default.
• W2005524757 creator A5069595034 @default.
• W2005524757 creator A5072568019 @default.
• W2005524757 creator A5081227680 @default.
• W2005524757 date "2015-04-10" @default.
• W2005524757 modified "2023-10-16" @default.
• W2005524757 title "Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model" @default.
• W2005524757 cites W1561679936 @default.
• W2005524757 cites W1584995205 @default.
• W2005524757 cites W1915312094 @default.
• W2005524757 cites W1924178040 @default.
• W2005524757 cites W1926553705 @default.
• W2005524757 cites W1967773087 @default.
• W2005524757 cites W1968871586 @default.
• W2005524757 cites W1976160361 @default.
• W2005524757 cites W1982519052 @default.
• W2005524757 cites W1983255179 @default.
• W2005524757 cites W1985892848 @default.
• W2005524757 cites W1998479457 @default.
• W2005524757 cites W2002507728 @default.
• W2005524757 cites W2011769994 @default.
• W2005524757 cites W2015458565 @default.
• W2005524757 cites W2017722783 @default.
• W2005524757 cites W2028561148 @default.
• W2005524757 cites W2029575320 @default.
• W2005524757 cites W2032775466 @default.
• W2005524757 cites W2033479268 @default.
• W2005524757 cites W2034227377 @default.
• W2005524757 cites W2039647109 @default.
• W2005524757 cites W2048503326 @default.
• W2005524757 cites W2051051686 @default.
• W2005524757 cites W2075381893 @default.
• W2005524757 cites W2080740849 @default.
• W2005524757 cites W2084858898 @default.
• W2005524757 cites W2088853162 @default.
• W2005524757 cites W2100382637 @default.
• W2005524757 cites W2105416725 @default.
• W2005524757 cites W2110498109 @default.
• W2005524757 cites W2138985949 @default.
• W2005524757 cites W2143801014 @default.
• W2005524757 cites W2144423648 @default.
• W2005524757 cites W2146970599 @default.
• W2005524757 cites W2158282653 @default.
• W2005524757 cites W2161824703 @default.
• W2005524757 cites W2298519186 @default.
• W2005524757 cites W2329817100 @default.
• W2005524757 cites W2401485211 @default.
• W2005524757 cites W2408999581 @default.
• W2005524757 doi "https://doi.org/10.1007/s11307-015-0832-x" @default.
• W2005524757 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4641156" @default.
• W2005524757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25860122" @default.
• W2005524757 hasPublicationYear "2015" @default.
• W2005524757 type Work @default.
• W2005524757 sameAs 2005524757 @default.
• W2005524757 citedByCount "15" @default.
• W2005524757 countsByYear W20055247572016 @default.
• W2005524757 countsByYear W20055247572017 @default.
• W2005524757 countsByYear W20055247572018 @default.
• W2005524757 countsByYear W20055247572019 @default.
• W2005524757 countsByYear W20055247572020 @default.
• W2005524757 countsByYear W20055247572021 @default.
• W2005524757 countsByYear W20055247572023 @default.
• W2005524757 crossrefType "journal-article" @default.
• W2005524757 hasAuthorship W2005524757A5010369186 @default.
• W2005524757 hasAuthorship W2005524757A5027422217 @default.
• W2005524757 hasAuthorship W2005524757A5041743198 @default.
• W2005524757 hasAuthorship W2005524757A5062101314 @default.
• W2005524757 hasAuthorship W2005524757A5068817061 @default.
• W2005524757 hasAuthorship W2005524757A5069595034 @default.
• W2005524757 hasAuthorship W2005524757A5072568019 @default.
• W2005524757 hasAuthorship W2005524757A5081227680 @default.
• W2005524757 hasBestOaLocation W20055247571 @default.
• W2005524757 hasConcept C104317684 @default.
• W2005524757 hasConcept C150903083 @default.
• W2005524757 hasConcept C153911025 @default.
• W2005524757 hasConcept C185592680 @default.
• W2005524757 hasConcept C202751555 @default.
• W2005524757 hasConcept C207001950 @default.
• W2005524757 hasConcept C2777807558 @default.
• W2005524757 hasConcept C2779489039 @default.
• W2005524757 hasConcept C523546767 @default.
• W2005524757 hasConcept C54355233 @default.
• W2005524757 hasConcept C547475151 @default.
• W2005524757 hasConcept C55493867 @default.
• W2005524757 hasConcept C86803240 @default.
• W2005524757 hasConcept C89423630 @default.
• W2005524757 hasConceptScore W2005524757C104317684 @default.
• W2005524757 hasConceptScore W2005524757C150903083 @default.
• W2005524757 hasConceptScore W2005524757C153911025 @default.
• W2005524757 hasConceptScore W2005524757C185592680 @default.
• W2005524757 hasConceptScore W2005524757C202751555 @default.
• W2005524757 hasConceptScore W2005524757C207001950 @default.

• next